Financial Statements — TRMD
Balance Sheet
(in billions USD)| Metric | Q2
2025 | Q2
2024 | Q3
2023 | Q2
2022 | Q3
2021 |
|---|
| Cash & Equivalents | 0.36 | 0.53 | 0.24 | 0.13 | 0.10 |
| Inventory | 0.07 | 0.07 | 0.07 | -- | -- |
| Total Current Assets | 0.68 | 0.92 | 0.68 | 0.56 | 0.26 |
| Goodwill | 0.00 | 0.00 | 0.00 | -- | -- |
| Total Non-current Assets | 2.71 | 2.55 | 2.13 | 1.86 | 1.97 |
| Total Assets | 3.40 | 3.47 | 2.81 | 2.42 | 2.24 |
| Total Current Liabilities | 0.27 | 0.29 | 0.29 | 0.25 | 0.28 |
| Total Non-current Liabilities | 1.02 | 1.13 | 0.95 | 0.96 | 0.91 |
| Total Liabilities | 1.29 | 1.42 | 1.24 | 1.21 | 1.19 |
| Retained Earnings | 1.60 | 1.53 | 1.31 | 1.02 | 0.91 |
| Total Stockholder Equity | 2.11 | 2.04 | 1.57 | 1.21 | 1.05 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q3
2023 | Q2
2022 | Q3
2021 |
|---|
| Total Operating Expenses | 64.30 | 62.70 | 54.20 | 51.10 | 48.90 |
| Operating Income | 74.60 | 204.30 | 140.00 | 118.70 | (3.70) |
| Pretax Income | 60.40 | 193.10 | 127.70 | 107.00 | (14.10) |
| Tax Provision | 1.70 | (1.10) | 3.40 | 0.40 | 0.60 |
| Net Income | 58.70 | 194.20 | 124.30 | 106.60 | -- |
| Basic EPS | 0.60 | 2.08 | 1.47 | 1.31 | (0.18) |
| Diluted EPS | 0.58 | 2.02 | 1.42 | 1.31 | (0.19) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q3
2023 | Q2
2022 | Q3
2021 |
|---|
| Operating Cash Flow | 244.40 | 468.40 | 202.90 | 89.00 | 35.20 |
| Investing Cash Flow | 48.50 | (150.00) | (6.10) | (14.20) | (221.90) |
| Financing Cash Flow | (205.00) | (56.80) | (195.60) | (86.30) | 201.40 |
